Zobrazeno 1 - 10
of 4 306
pro vyhledávání: '"Harvey RD"'
Autor:
Sherpa RT; Department of Pharmacology, University of Nevada, Reno School of Medicine, Reno, Nevada, USA., Moshal KS; Department of Pharmacology, University of Nevada, Reno School of Medicine, Reno, Nevada, USA., Agarwal SR; Department of Pharmacology, University of Nevada, Reno School of Medicine, Reno, Nevada, USA., Ostrom RS; Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, California, USA., Harvey RD; Department of Pharmacology, University of Nevada, Reno School of Medicine, Reno, Nevada, USA.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2024 Aug; Vol. 181 (15), pp. 2622-2635. Date of Electronic Publication: 2024 Apr 12.
Autor:
Thota R; Intermountain Health, Murray, UT., Hurley PA; American Society of Clinical Oncology, Alexandria VA., Miller TM; Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY., Bruinooge SS; American Society of Clinical Oncology, Alexandria VA., Lipset C; Decentralized Trials and Research Alliance, San Diego, CA., Harvey RD; Winship Cancer Institute of Emory University, Atlanta, GA., Black LJ; Sanford Health, Sioux Falls, SD., Dinsdale A; Montana Cancer Consortium, Billings, MT., Merrill JK; American Society of Clinical Oncology, Alexandria VA., Pollastro T; Metastatic Breast Cancer Alliance, New York, NY., Prindiville SA; NCI Coordinating Center for Clinical Trials, Bethesda, MD., Rizvi MA; Heimann Cancer Center, Asante Health System, Medford, OR., Sherwood S; American Society of Clinical Oncology, Alexandria VA., Nowakowski GS; Mayo Clinic, Rochester, MN.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jul 30, pp. JCO2400961. Date of Electronic Publication: 2024 Jul 30.
Publikováno v:
American Journal of Men's Health, Vol 14 (2020)
Overweight and obese men were recruited to a 6-month, randomized controlled weight loss trial, which compared the Gutbusters weight loss program alone to the Gutbusters program with incentives for successful weight loss. The intervention was delivere
Externí odkaz:
https://doaj.org/article/29e96e58b63d443b99153966b6239e3b
Autor:
Harvey RD; Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Miller TM; Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, New York, USA., Hurley PA; American Society of Clinical Oncology, Alexandria, Virginia, USA., Thota R; Intermountain Health, Salt Lake City, Utah, USA., Black LJ; Sanford Health, Sioux Falls, South Dakota, USA., Bruinooge SS; American Society of Clinical Oncology, Alexandria, Virginia, USA., Boehmer LM; Association of Community Cancer Centers, Rockville, Maryland, USA., Fleury ME; American Cancer Society Cancer Action Network, Washington, District of Columbia, USA., Kamboj J; Allina Health System, River Falls, Wisconsin, USA., Rizvi MA; Hematology Oncology Associates, Medford, Oregon, USA., Symington BE; Sweetwater Regional Cancer Center, Rock Springs, Wyoming, USA., Tap WD; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Waterhouse DM; Oncology Hematology Care, Inc., Cincinnati, Ohio, USA., Levit LA; American Society of Clinical Oncology, Alexandria, Virginia, USA., Merrill JK; American Society of Clinical Oncology, Alexandria, Virginia, USA., Prindiville SA; National Cancer Institute Coordinating Center for Clinical Trials, Bethesda, Maryland, USA., Pollastro T; Metastatic Breast Cancer Alliance, Mercer Island, Washington, USA., Brewer JR; US Food and Drug Administration, Rockville, Maryland, USA., Byatt LP; New Mexico Cancer Care Alliance, Albuquerque, New Mexico, USA., Hamroun L; ChristianaCare OPACT, Newark, Delaware, USA., Kim ES; City of Hope, Duarte, California, USA., Holland N; American Society of Clinical Oncology, Alexandria, Virginia, USA., Nowakowski GS; Mayo Clinic, Rochester, Minnesota, USA.
Publikováno v:
Cancer [Cancer] 2024 Apr 15; Vol. 130 (8), pp. 1193-1203. Date of Electronic Publication: 2024 Jan 09.
Autor:
Knippler CM; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.; Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA., Arnst JL; Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.; Department of Medicine, Division of Endocrinology, Emory University, Atlanta, GA 30322, USA., Robinson IE; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.; Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.; George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA 30318, USA., Matsuk V; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.; Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.; Graduate Program in Cancer Biology, Emory University, Atlanta, GA 30322, USA., Khatib TO; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.; Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.; Graduate Program in Biochemistry, Cell, and Developmental Biology, Emory University, Atlanta, GA 30322, USA., Harvey RD; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.; Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.; Department of Pharmacology and Chemical Biology, Emory University, Atlanta, GA 30322, USA., Shanmugam M; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.; Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA., Mouw JK; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.; Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA., Fu H; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.; Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.; Department of Pharmacology and Chemical Biology, Emory University, Atlanta, GA 30322, USA., Ganesh T; Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.; Department of Pharmacology and Chemical Biology, Emory University, Atlanta, GA 30322, USA., Marcus AI; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.; Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.
Publikováno v:
IScience [iScience] 2024 Mar 27; Vol. 27 (4), pp. 109591. Date of Electronic Publication: 2024 Mar 27 (Print Publication: 2024).
Autor:
Falchook G; Sarah Cannon Research Institute at HealthONE, Denver, Colorado., Patnaik A; START San Antonio, San Antonio, Texas., Richardson DL; Gynecologic Oncology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; Sarah Cannon Research Institute, Oklahoma City, Oklahoma., Harvey RD; Emory University School of Medicine, Atlanta, Georgia., Sharma MR; START Midwest, Grand Rapids, Michigan., Hafez N; Yale Cancer Center, New Haven, Connecticut., Hamilton E; Sarah Cannon Research Institute at Tennessee Oncology, Nashville, Tennessee., Piha-Paul SA; Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas., Barve M; Mary Crowley Cancer Research Center, Dallas, Texas., Wise-Draper T; University of Cincinnati Cancer Center, Cincinnati, Ohio., Patel MR; Florida Cancer Specialists, Sarasota, Florida; Sarah Cannon Research Institute, Sarasota, Florida., Dowlati A; University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, Ohio., Pascuzzo J; Medical Oncology, California Cancer Associates for Research and Excellence, San Diego, California., Tang SC; Cancer Center and Research Institute, University of Mississippi Medical Center, Jackson, Mississippi., Faltermeier C; Pharmacokinetics, IQVIA, Kansas City, Missouri., Malinowska IA; Oncology Clinical Development, GSK, Waltham, Massachusetts., Shtessel L; Oncology Clinical Development, GSK, Waltham, Massachusetts., Striha A; Plus-Project Partnership Ltd, Knutsford, UK., Potocka E; Clinical Pharmacology Modeling and Simulation, GSK, Waltham, Massachusetts. Electronic address: ella.x.potocka@gsk.com.
Publikováno v:
Clinical therapeutics [Clin Ther] 2024 Mar; Vol. 46 (3), pp. 228-238. Date of Electronic Publication: 2024 Feb 28.
Autor:
Juric D; Termeer Center for Targeted Therapies, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Barve M; Medical Oncology, Mary Crowley Cancer Research, Dallas, Texas, USA., Vaishampayan U; Internal Medicine/Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA., Roda D; Department of Medical Oncology, University Hospital, Valencia, Spain., Calvo A; Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Jañez NM; Department of Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Trigo J; Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain., Greystoke A; Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Harvey RD; Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Olszanski AJ; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA., Opyrchal M; Division of Oncology, Washington University School of Medicine in St Louis, St Louis, Missouri, USA., Spira A; Medical Oncology, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.; Medical Oncology, Virginia Cancer Specialists, US Oncology Research, NEXT Oncology Virginia, Leesburg, Virginia, USA., Thistlethwaite F; Medical Oncology, The Christie NHS Foundation Trust and University of Manchester, Manchester, UK., Jiménez B; Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain., Sappal JH; Precision and Translational Medicine, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Kannan K; Oncology Therapeutic Area Unit, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Riley J; Gastroenterology, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Li C; Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Li C; Statistical and Quantitative Sciences, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Gregory RC; Precision and Translational Medicine, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Miao H; Clinical Development, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Wang S; Takeda Oncology Clinical Science, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5).
Autor:
Wölk C; Pharmaceutical Technology, Medical Faculty, University Leipzig, Eilenburger Straße 15a, 04317 Leipzig, Germany., Shen C; Deutsches Elektronen-Synchrotron DESY, Notkestr. 85, 22607 Hamburg, Germany., Hause G; Biocenter, Martin-Luther University Halle-Wittenberg, Weinbergweg 22, 06120 Halle (Saale), Germany., Surya W; School of Biological Sciences, Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798, Singapore., Torres J; School of Biological Sciences, Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798, Singapore., Harvey RD; Division of Pharmaceutical Chemistry, Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, UZA 2, Vienna 1090, Austria., Bello G; Division of Pharmaceutical Chemistry, Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, UZA 2, Vienna 1090, Austria.
Publikováno v:
Langmuir : the ACS journal of surfaces and colloids [Langmuir] 2024 Feb 06; Vol. 40 (5), pp. 2646-2655. Date of Electronic Publication: 2024 Jan 22.
Autor:
Carneiro BA; Legorreta Cancer Center, Brown University and Lifespan Cancer Institute, Providence, Rhode Island., Cavalcante L; Novant Health Cancer Institute, Charlotte, North Carolina., Mahalingam D; Robert H. Lurie Cancer Center of Northwestern University, Chicago, Illinois., Saeed A; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania., Safran H; Legorreta Cancer Center, Brown University and Lifespan Cancer Institute, Providence, Rhode Island., Ma WW; Cleveland Clinic, Cleveland, Ohio., Coveler AL; Fred Hutchinson Cancer Center, Seattle, Washington., Powell S; Sanford Health, University of South Dakota Medical Center, Sioux Falls, South Dakota., Bastos B; Miami Cancer Institute at Baptist Health, Miami, Florida., Davis E; Vanderbilt University Medical Center, Nashville, Tennessee., Sahai V; University of Michigan, Ann Arbor, Michigan., Mikrut W; Vantage Data Designs, Austin, Texas., Longstreth J; Longstreth & Associates, Mundelein, Illinois., Smith S; Courante Oncology, Minneapolis, Minnesota., Weisskittel T; Mayo Clinic Cancer Center, Rochester, Minnesota., Li H; Mayo Clinic Cancer Center, Rochester, Minnesota., Borden BA; Legorreta Cancer Center, Brown University and Lifespan Cancer Institute, Providence, Rhode Island., Harvey RD; Emory University, Atlanta, Georgia., Sahebjam S; Johns Hopkins University, Baltimore, Maryland., Cervantes A; Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain., Koukol A; Actuate Therapeutics, Fort Worth, Texas., Mazar AP; Actuate Therapeutics, Fort Worth, Texas., Steeghs N; Netherlands Cancer Institute, Amsterdam, the Netherlands., Kurzrock R; Medical College of Wisconsin, Milwaukee, Wisconsin., Giles FJ; Developmental Therapeutics LLC, Chicago, Illinois., Munster P; University of California San Francisco, San Francisco, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Feb 01; Vol. 30 (3), pp. 522-531.
Publikováno v:
American Journal of Men's Health, Vol 13 (2019)
Obese men are at an increased risk of chronic disease and are far less likely than women to attempt weight loss. There is a need to successfully recruit men to weight loss clinical trials. Overweight and obese men were recruited to a 6-month, randomi
Externí odkaz:
https://doaj.org/article/0fe05cff504b44e887bff219f051404b